Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Sharon Pine

Concepts (295)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
30
2023
2200
3.250
 Why?
Carcinoma, Non-Small-Cell Lung
9
2023
962
1.630
 Why?
Amyloid Precursor Protein Secretases
3
2018
71
1.270
 Why?
SOX9 Transcription Factor
3
2023
23
1.230
 Why?
Biomarkers, Tumor
10
2021
1046
1.160
 Why?
Leukemia, Megakaryoblastic, Acute
4
2007
10
0.900
 Why?
Receptor, Notch1
2
2014
59
0.880
 Why?
GATA1 Transcription Factor
4
2007
13
0.860
 Why?
DNA, Neoplasm
4
2010
157
0.790
 Why?
STAT Transcription Factors
1
2021
13
0.790
 Why?
Janus Kinases
1
2021
12
0.790
 Why?
Paclitaxel
2
2022
190
0.740
 Why?
Signal Transduction
9
2021
4527
0.740
 Why?
Inflammation
4
2022
2485
0.670
 Why?
Neoplastic Stem Cells
3
2013
332
0.660
 Why?
Carcinoma, Squamous Cell
3
2022
577
0.650
 Why?
Down Syndrome
4
2007
336
0.630
 Why?
Cell Line, Tumor
13
2023
2715
0.610
 Why?
Benzodiazepinones
1
2017
14
0.600
 Why?
Protease Inhibitors
1
2018
100
0.590
 Why?
Antineoplastic Agents
7
2023
1882
0.580
 Why?
Gene Expression Regulation, Neoplastic
8
2022
1145
0.580
 Why?
F-Box Proteins
1
2016
20
0.540
 Why?
Drug Resistance, Neoplasm
6
2021
636
0.540
 Why?
Antineoplastic Agents, Phytogenic
1
2017
181
0.530
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2005
269
0.530
 Why?
Proteasome Endopeptidase Complex
1
2016
135
0.530
 Why?
Ubiquitin-Protein Ligases
1
2016
139
0.500
 Why?
Polymerase Chain Reaction
5
2010
1000
0.500
 Why?
Interleukin-8
3
2014
238
0.490
 Why?
Neoplasms
2
2021
2106
0.470
 Why?
DNA Damage
1
2016
357
0.460
 Why?
Neoplasms, Basal Cell
1
2013
3
0.460
 Why?
Chromosome Segregation
1
2013
36
0.450
 Why?
Cell Cycle Proteins
1
2016
551
0.420
 Why?
Interleukin-6
3
2019
676
0.410
 Why?
DNA
2
2022
1353
0.410
 Why?
Adenocarcinoma
3
2017
795
0.410
 Why?
C-Reactive Protein
2
2011
363
0.400
 Why?
Mannose-Binding Lectin
2
2009
21
0.380
 Why?
Humans
48
2023
115222
0.370
 Why?
Proto-Oncogene Proteins c-mdm2
2
2012
57
0.360
 Why?
Oncogene Proteins, Fusion
3
2017
179
0.360
 Why?
Mutation
9
2023
3350
0.360
 Why?
Mice
12
2023
14934
0.350
 Why?
Cell Transformation, Neoplastic
2
2021
311
0.350
 Why?
Case-Control Studies
13
2020
3023
0.330
 Why?
Polymorphism, Single Nucleotide
6
2019
1902
0.330
 Why?
Smoking
5
2022
1392
0.330
 Why?
Cytokines
1
2015
1843
0.300
 Why?
Polymorphism, Genetic
2
2009
618
0.300
 Why?
Animals
14
2023
31884
0.300
 Why?
Proto-Oncogene Proteins p21(ras)
3
2023
228
0.290
 Why?
Molecular Targeted Therapy
2
2021
347
0.290
 Why?
Inflammation Mediators
2
2021
476
0.290
 Why?
Lymphoma, AIDS-Related
1
2007
13
0.290
 Why?
Leukemia
2
2007
209
0.280
 Why?
Lymphoproliferative Disorders
1
2007
46
0.280
 Why?
Lymphoma, Non-Hodgkin
1
2007
72
0.270
 Why?
Cell Proliferation
7
2021
2192
0.260
 Why?
Breast Neoplasms
2
2013
1865
0.250
 Why?
Female
29
2022
59720
0.240
 Why?
Tumor Microenvironment
3
2023
431
0.240
 Why?
Aged
18
2022
19136
0.230
 Why?
Carboplatin
2
2022
135
0.230
 Why?
Central Nervous System Neoplasms
1
2005
126
0.220
 Why?
Genes, ras
1
2023
91
0.220
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2022
76
0.200
 Why?
Intracellular Signaling Peptides and Proteins
2
2022
386
0.200
 Why?
Cell Movement
3
2020
866
0.200
 Why?
Epithelial-Mesenchymal Transition
2
2014
167
0.200
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2022
95
0.200
 Why?
Pyrazines
1
2022
71
0.200
 Why?
Base Sequence
4
2014
2120
0.200
 Why?
Immunity, Innate
1
2007
723
0.200
 Why?
Middle Aged
17
2020
26873
0.200
 Why?
Ribosome Subunits, Large, Eukaryotic
1
2021
2
0.190
 Why?
Superoxide Dismutase-1
1
2021
8
0.190
 Why?
Organelle Biogenesis
1
2021
15
0.190
 Why?
Triazoles
1
2022
130
0.190
 Why?
Cytokinesis
1
2021
46
0.190
 Why?
Adenocarcinoma, Mucinous
1
2021
61
0.180
 Why?
Male
23
2022
55814
0.180
 Why?
Phosphatidylinositol 3-Kinases
1
2022
332
0.180
 Why?
Cellular Senescence
2
2013
153
0.180
 Why?
Biomarkers
2
2021
3422
0.180
 Why?
Proto-Oncogene Proteins c-akt
1
2022
401
0.180
 Why?
Receptors, Kisspeptin-1
1
2020
2
0.180
 Why?
Molecular Chaperones
1
2021
157
0.180
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2019
9
0.170
 Why?
Janus Kinase 2
1
2019
31
0.170
 Why?
Molecular Sequence Data
3
2014
2797
0.170
 Why?
Disease Susceptibility
1
2021
316
0.170
 Why?
TOR Serine-Threonine Kinases
1
2022
358
0.170
 Why?
Mice, Inbred NOD
2
2020
559
0.170
 Why?
Cellular Reprogramming
1
2020
84
0.160
 Why?
Risk Factors
8
2015
8658
0.160
 Why?
Acrylamides
1
2019
42
0.160
 Why?
Aniline Compounds
1
2019
71
0.160
 Why?
Neoplasm, Residual
3
2005
105
0.160
 Why?
Combined Modality Therapy
1
2021
1130
0.160
 Why?
Proteolysis
2
2016
144
0.160
 Why?
Nanotechnology
1
2019
113
0.160
 Why?
Carcinogenesis
1
2020
178
0.160
 Why?
Lung
4
2022
3595
0.160
 Why?
Quinolines
1
2019
129
0.150
 Why?
Prognosis
6
2021
3336
0.150
 Why?
Cancer Survivors
1
2022
204
0.150
 Why?
Tumor Suppressor Protein p53
2
2013
447
0.150
 Why?
Receptors, Notch
1
2018
85
0.150
 Why?
Disease Management
1
2021
562
0.150
 Why?
Transfection
2
2017
872
0.150
 Why?
Quinazolines
1
2019
240
0.150
 Why?
Triple Negative Breast Neoplasms
1
2020
157
0.150
 Why?
CD24 Antigen
2
2013
20
0.140
 Why?
Neoplasm Invasiveness
2
2020
443
0.140
 Why?
F-Box-WD Repeat-Containing Protein 7
1
2016
6
0.140
 Why?
Glycogen Synthase Kinase 3 beta
1
2016
61
0.140
 Why?
Hyaluronan Receptors
2
2013
91
0.140
 Why?
Proportional Hazards Models
2
2011
1082
0.140
 Why?
Ubiquitination
1
2016
86
0.130
 Why?
Coculture Techniques
2
2013
202
0.130
 Why?
Protein Interaction Domains and Motifs
1
2016
132
0.130
 Why?
Computational Biology
1
2019
532
0.130
 Why?
Software
1
2019
538
0.130
 Why?
Proto-Oncogene Proteins B-raf
1
2017
192
0.130
 Why?
Protein Kinase Inhibitors
2
2019
787
0.120
 Why?
Cell Division
3
2013
759
0.120
 Why?
Receptors, Interleukin-8B
1
2014
23
0.120
 Why?
Protein Isoforms
2
2013
339
0.120
 Why?
Disease Progression
1
2021
2390
0.120
 Why?
Cell Death
1
2016
324
0.120
 Why?
Energy Metabolism
1
2020
730
0.120
 Why?
Colorectal Neoplasms
1
2021
617
0.120
 Why?
Patient Selection
1
2018
651
0.120
 Why?
Tumor Cells, Cultured
2
2021
851
0.120
 Why?
3' Untranslated Regions
1
2014
133
0.120
 Why?
Ultraviolet Rays
1
2016
368
0.110
 Why?
Research Design
2
2011
933
0.110
 Why?
Platinum Compounds
1
2013
9
0.110
 Why?
Genes, T-Cell Receptor
2
2003
6
0.110
 Why?
Models, Biological
2
2019
1638
0.110
 Why?
Dipeptides
1
2013
48
0.110
 Why?
Lymphocytes, Tumor-Infiltrating
1
2013
111
0.110
 Why?
Core Binding Factor Alpha 2 Subunit
2
2003
31
0.110
 Why?
Alleles
3
2014
792
0.110
 Why?
HIV Infections
1
2007
2470
0.110
 Why?
Immunoglobulin Heavy Chains
2
2003
72
0.110
 Why?
Gene Expression Regulation
1
2021
2330
0.100
 Why?
Survival Analysis
2
2013
1215
0.100
 Why?
Stromal Cells
1
2012
96
0.100
 Why?
Gap Junctions
1
2012
58
0.100
 Why?
Adult
8
2020
30711
0.100
 Why?
Phosphorylation
1
2016
1574
0.100
 Why?
Genotype
4
2014
1781
0.100
 Why?
Risk Assessment
3
2011
2981
0.100
 Why?
Bone Marrow Cells
1
2012
267
0.100
 Why?
National Cancer Institute (U.S.)
1
2011
40
0.100
 Why?
Cell Communication
1
2012
280
0.090
 Why?
Protein Binding
1
2016
1898
0.090
 Why?
Melanoma
1
2017
623
0.090
 Why?
Phenotype
3
2013
2814
0.090
 Why?
AC133 Antigen
1
2010
19
0.090
 Why?
Bromodeoxyuridine
1
2010
72
0.090
 Why?
Infant
3
2007
7966
0.080
 Why?
Biopsy
2
2017
1050
0.080
 Why?
Logistic Models
2
2011
1841
0.080
 Why?
CD8-Positive T-Lymphocytes
1
2013
691
0.080
 Why?
Exons
2
2008
301
0.080
 Why?
DNA Replication
1
2010
202
0.080
 Why?
Cell Differentiation
2
2008
1700
0.080
 Why?
Genetic Predisposition to Disease
4
2012
2109
0.080
 Why?
Prospective Studies
2
2011
6245
0.080
 Why?
Glycoproteins
1
2010
305
0.080
 Why?
Baltimore
1
2007
43
0.070
 Why?
Polymorphism, Single-Stranded Conformational
1
2007
26
0.070
 Why?
Antigens, CD
1
2010
441
0.070
 Why?
Infant, Newborn
3
2007
5052
0.070
 Why?
Smoking Cessation
1
2011
376
0.070
 Why?
Sequence Homology, Nucleic Acid
1
2007
152
0.070
 Why?
Linkage Disequilibrium
1
2007
245
0.070
 Why?
Tobacco Smoke Pollution
1
2009
217
0.070
 Why?
Autophagy
2
2023
234
0.070
 Why?
Neoplasm Staging
3
2017
1171
0.070
 Why?
Superoxide Dismutase
1
2008
305
0.070
 Why?
United States
3
2020
12256
0.070
 Why?
Predictive Value of Tests
1
2011
1816
0.070
 Why?
DNA Primers
2
2008
515
0.070
 Why?
ErbB Receptors
2
2019
555
0.070
 Why?
In Situ Hybridization, Fluorescence
1
2007
310
0.070
 Why?
Disease-Free Survival
1
2007
619
0.060
 Why?
Haplotypes
1
2007
455
0.060
 Why?
Chromosomes, Human, Pair 21
1
2005
31
0.060
 Why?
Gene Knockdown Techniques
2
2021
299
0.060
 Why?
Preservation, Biological
1
2005
7
0.060
 Why?
Remission Induction
1
2005
237
0.060
 Why?
Mice, Knockout
2
2021
2586
0.060
 Why?
MicroRNAs
3
2019
604
0.060
 Why?
Peptides
1
2010
849
0.060
 Why?
Cloning, Molecular
1
2005
524
0.060
 Why?
Reproducibility of Results
2
2019
2806
0.060
 Why?
Chronology as Topic
1
2003
2
0.050
 Why?
Chromosome Breakage
1
2003
21
0.050
 Why?
Gene Expression
1
2008
1424
0.050
 Why?
Mitogen-Activated Protein Kinase Kinases
1
2023
114
0.050
 Why?
Clone Cells
1
2003
248
0.050
 Why?
Mucins
1
2022
61
0.050
 Why?
Child
4
2009
18468
0.050
 Why?
Immunophenotyping
1
2003
276
0.050
 Why?
Promoter Regions, Genetic
1
2006
1133
0.050
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2003
66
0.050
 Why?
Apoptosis
2
2021
2368
0.050
 Why?
Cell Nucleolus
1
2021
17
0.050
 Why?
Time Factors
1
2011
6157
0.050
 Why?
Gene Expression Profiling
2
2019
1524
0.050
 Why?
Child, Preschool
2
2005
9124
0.050
 Why?
Adenosine
1
2022
204
0.050
 Why?
RNA Processing, Post-Transcriptional
1
2021
82
0.040
 Why?
Aftercare
1
2022
186
0.040
 Why?
Fibrosis
1
2022
455
0.040
 Why?
Mutagenesis, Site-Directed
1
2021
345
0.040
 Why?
Down-Regulation
1
2022
599
0.040
 Why?
Glutaminase
1
2020
10
0.040
 Why?
RNA Precursors
1
2021
137
0.040
 Why?
Recurrence
1
2003
952
0.040
 Why?
Mice, Nude
1
2021
631
0.040
 Why?
Africa, Western
1
2019
16
0.040
 Why?
A549 Cells
1
2019
51
0.040
 Why?
Tumor Stem Cell Assay
1
2019
33
0.040
 Why?
Glutamine
1
2020
91
0.040
 Why?
Exome
1
2020
201
0.040
 Why?
Killer Cells, Natural
1
2022
383
0.040
 Why?
Nucleotides
1
2020
112
0.040
 Why?
Incidence
2
2019
2324
0.040
 Why?
Mice, SCID
1
2020
319
0.040
 Why?
Xenograft Model Antitumor Assays
1
2021
697
0.040
 Why?
Proto-Oncogene Proteins c-myc
1
2020
115
0.040
 Why?
Tumor Burden
1
2020
260
0.040
 Why?
Survivors
1
2022
410
0.040
 Why?
DNA Mutational Analysis
1
2019
372
0.040
 Why?
Immunotherapy
1
2022
474
0.040
 Why?
Young Adult
3
2020
10520
0.040
 Why?
STAT3 Transcription Factor
1
2019
174
0.040
 Why?
Cell Nucleus
1
2021
556
0.040
 Why?
ROC Curve
1
2019
447
0.040
 Why?
Genetic Therapy
1
2019
258
0.040
 Why?
DNA-Binding Proteins
1
2005
1318
0.040
 Why?
B-Lymphocytes
1
2003
772
0.040
 Why?
Health Status Disparities
1
2019
202
0.040
 Why?
Transcription Factors
1
2005
1531
0.040
 Why?
Risk
1
2019
816
0.030
 Why?
Positron Emission Tomography Computed Tomography
1
2017
69
0.030
 Why?
Follow-Up Studies
2
2019
4430
0.030
 Why?
MAP Kinase Signaling System
1
2017
276
0.030
 Why?
Neoplasm Metastasis
1
2017
524
0.030
 Why?
Survival Rate
1
2019
1650
0.030
 Why?
Japan
1
2014
88
0.030
 Why?
Leupeptins
1
2013
10
0.030
 Why?
Cell Survival
1
2017
1022
0.030
 Why?
Macrolides
1
2013
56
0.030
 Why?
Transduction, Genetic
1
2013
113
0.030
 Why?
Octamer Transcription Factor-3
1
2012
16
0.030
 Why?
Ligands
1
2014
565
0.030
 Why?
Mice, Inbred C57BL
1
2021
4718
0.030
 Why?
Cross-Sectional Studies
1
2022
4419
0.020
 Why?
Disease Models, Animal
1
2021
3547
0.020
 Why?
Binding Sites
1
2014
1173
0.020
 Why?
Cohort Studies
2
2012
4917
0.020
 Why?
Early Detection of Cancer
1
2014
339
0.020
 Why?
Neoplasm Proteins
1
2013
386
0.020
 Why?
Recombinant Proteins
1
2013
1237
0.020
 Why?
Genetic Variation
1
2014
876
0.020
 Why?
Adolescent
2
2009
17889
0.020
 Why?
Small Cell Lung Carcinoma
1
2010
77
0.020
 Why?
Confidence Intervals
1
2010
307
0.020
 Why?
Neoplasm Recurrence, Local
1
2014
859
0.020
 Why?
Age Distribution
1
2010
341
0.020
 Why?
Sex Distribution
1
2010
337
0.020
 Why?
Reference Values
1
2010
748
0.020
 Why?
Enzyme Stability
1
2008
62
0.020
 Why?
Aged, 80 and over
1
2019
6358
0.020
 Why?
Homozygote
1
2008
188
0.020
 Why?
Linear Models
1
2010
779
0.020
 Why?
Amino Acid Substitution
1
2008
262
0.020
 Why?
Odds Ratio
1
2010
958
0.020
 Why?
Colonic Neoplasms
1
2009
222
0.020
 Why?
Environmental Exposure
1
2009
377
0.020
 Why?
Cells, Cultured
1
2013
3897
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2008
928
0.020
 Why?
Comorbidity
1
2010
1458
0.020
 Why?
Erythroid-Specific DNA-Binding Factors
1
2005
18
0.020
 Why?
Genome-Wide Association Study
1
2010
1203
0.010
 Why?
Aneuploidy
1
2005
86
0.010
 Why?
Retrospective Studies
1
2014
12597
0.010
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2005
1354
0.010
 Why?
Pine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (295) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)